132 related articles for article (PubMed ID: 32674791)
1. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
Bloch MJ
J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
[TBL] [Abstract][Full Text] [Related]
2. Ramipril in High-Risk Patients With COVID-19.
Amat-Santos IJ; Santos-Martinez S; López-Otero D; Nombela-Franco L; Gutiérrez-Ibanes E; Del Valle R; Muñoz-García E; Jiménez-Diaz VA; Regueiro A; González-Ferreiro R; Benito T; Sanmartin-Pena XC; Catalá P; Rodríguez-Gabella T; Delgado-Arana JR; Carrasco-Moraleja M; Ibañez B; San Román JA
J Am Coll Cardiol; 2020 Jul; 76(3):268-276. PubMed ID: 32470515
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension, RAAS blockade and risk in COVID-19 patients].
Spaak J; Kahan T
Lakartidningen; 2020 Jun; 117():. PubMed ID: 32594472
[TBL] [Abstract][Full Text] [Related]
4. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
Sever P; Johnston SL
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
[No Abstract] [Full Text] [Related]
5. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
6. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
Çiftçiler R; Haznedaroğlu İC
Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
[No Abstract] [Full Text] [Related]
7. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
Quinn KL; Fralick M; Zipursky JS; Stall NM
CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
[No Abstract] [Full Text] [Related]
8. What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?
Elijovich F; Laffer CL
Hypertension; 2020 Sep; 76(3):665-669. PubMed ID: 32783759
[No Abstract] [Full Text] [Related]
9. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
10. Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.
Álvarez-Aragón LM; Cuesta-Muñoz AL; Álvarez-López I
Clin Infect Dis; 2020 Jul; 71(15):894-895. PubMed ID: 32266375
[No Abstract] [Full Text] [Related]
11. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
Patel AB; Verma A
Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
[No Abstract] [Full Text] [Related]
12. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
13. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
[No Abstract] [Full Text] [Related]
14. Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19.
Walther T; Kuebler WM
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1023-L1024. PubMed ID: 32364441
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
Cao Z; Wu Y; Faucon E; Sabatier JM
Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
[No Abstract] [Full Text] [Related]
16. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Mahajan K; Gaur N
Diabetes Metab Syndr; 2020; 14(5):723-724. PubMed ID: 32473902
[No Abstract] [Full Text] [Related]
17. Association between angiotensin blockade and COVID-19 severity in Hong Kong.
Cheung KS; Hung IFN; Leung WK
CMAJ; 2020 Jun; 192(23):E635. PubMed ID: 32575056
[No Abstract] [Full Text] [Related]
18. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
Williams B; Zhang Y
Lancet; 2020 May; 395(10238):1671-1673. PubMed ID: 32416786
[No Abstract] [Full Text] [Related]
19. Reply to Letter to the Editor: "Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19".
Abassi ZA; Skorecki K; Heyman SN; Kinaneh S; Armaly Z
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1029-L1030. PubMed ID: 32364440
[No Abstract] [Full Text] [Related]
20. ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
Wang Y; Tse G; Li G; Lip GYH; Liu T
J Am Coll Cardiol; 2020 Oct; 76(17):2041. PubMed ID: 33092742
[No Abstract] [Full Text] [Related]
[Next] [New Search]